Virtus ETF Advisers’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $333K | Sell |
|
|||||
|
2024
Q3 | $331K | Hold |
|
|||||
|
2024
Q2 | $273K | Sell |
|
|||||
|
2024
Q1 | $402K | Buy |
|
|||||
|
2023
Q4 | $326K | Buy |
|
|||||
|
2023
Q3 | $159K | Sell |
|
|||||
|
2023
Q2 | $325K | Buy |
|
|||||
|
2023
Q1 | $377K | Buy |
|
|||||
|
2022
Q4 | $292K | Sell |
|
|||||
|
2022
Q3 | $461K | Buy |
|
|||||
|
2022
Q2 | $362K | Sell |
|
|||||
|
2022
Q1 | $374K | Hold |
|
|||||
|
2021
Q4 | $400K | Sell |
|
|||||
|
2021
Q3 | $388K | Sell |
|
|||||
|
2021
Q2 | $481K | Buy |
|
|||||
|
2021
Q1 | $449K | Buy |
|
|||||
|
2020
Q4 | $563K | Sell |
|
|||||
|
2020
Q3 | $555K | Buy |
|
|||||
|
2020
Q2 | $551K | Sell |
|
|||||
|
2020
Q1 | $544K | Sell |
|
|||||
|
2019
Q4 | $635K | Buy |
|
|||||
|
2019
Q3 | $213K | Sell |
|
|||||
|
2019
Q2 | $300K | Sell |
|
|||||
|
2019
Q1 | $299K | Sell |
|
|||||
|
2018
Q4 | $297K | Sell |
|
|||||
|
2018
Q3 | $579K | Sell |
|
|||||
|
2018
Q2 | $713K | Sell |
|
|||||
|
2018
Q1 | $1.27M | Buy |
|
|||||
|
2017
Q4 | $363K | Buy |
|
|||||
|
2017
Q3 | $392K | Buy |
|
|||||
|
2017
Q2 | $327K | Sell |
|
|||||
|
2017
Q1 | $223K | Buy |
|
|||||
|
2016
Q4 | $224K | Sell |
|
|||||
|
2016
Q3 | $488K | Hold |
|
|||||
|
2016
Q2 | $245K | Buy |
|
|||||
|
2016
Q1 | $57K | Buy |
|